Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Human anti-nucleolin recombinant immunoagent for cancer therapy.
Palmieri D, Richmond T, Piovan C, Sheetz T, Zanesi N, Troise F, James C, Wernicke D, Nyei F, Gordon TJ, Consiglio J, Salvatore F, Coppola V, Pichiorri F, De Lorenzo C, Croce CM. Palmieri D, et al. Among authors: troise f. Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):9418-23. doi: 10.1073/pnas.1507087112. Epub 2015 Jul 13. Proc Natl Acad Sci U S A. 2015. PMID: 26170308 Free PMC article.
Vector Aided Microenvironment programming (VAMP): reprogramming the TME with MVA virus expressing IL-12 for effective antitumor activity.
Seclì L, Infante L, Nocchi L, De Lucia M, Cotugno G, Leoni G, Micarelli E, Garzia I, Avalle L, Sdruscia G, Troise F, Allocca S, Romano G, Scarselli E, D'Alise AM. Seclì L, et al. Among authors: troise f. J Immunother Cancer. 2023 Apr;11(4):e006718. doi: 10.1136/jitc-2023-006718. J Immunother Cancer. 2023. PMID: 37117006 Free PMC article.
Development of a Potency Assay for Nous-209, a Multivalent Neoantigens-Based Genetic Cancer Vaccine.
Bartolomeo R, Troise F, Allocca S, Sdruscia G, Vitale R, Bignone V, Petrone AM, Romano G, D'Alise AM, Ruzza V, Garzia I, Leoni G, Merone R, Lanzaro F, Colloca S, Siani L, Scarselli E, Cotugno G. Bartolomeo R, et al. Among authors: troise f. Vaccines (Basel). 2024 Mar 19;12(3):325. doi: 10.3390/vaccines12030325. Vaccines (Basel). 2024. PMID: 38543959 Free PMC article.
A novel ErbB2 epitope targeted by human antitumor immunoagents.
Troise F, Monti M, Merlino A, Cozzolino F, Fedele C, Russo Krauss I, Sica F, Pucci P, D'Alessio G, De Lorenzo C. Troise F, et al. FEBS J. 2011 Apr;278(7):1156-66. doi: 10.1111/j.1742-4658.2011.08041.x. Epub 2011 Mar 1. FEBS J. 2011. PMID: 21288302 Free article.
Rapid Affinity Maturation of Novel Anti-PD-L1 Antibodies by a Fast Drop of the Antigen Concentration and FACS Selection of Yeast Libraries.
Cembrola B, Ruzza V, Troise F, Esposito ML, Sasso E, Cafaro V, Passariello M, Visconte F, Raia M, Del Vecchio L, D'Alise AM, Cortese R, Scarselli E, Zambrano N, De Lorenzo C, Nicosia A. Cembrola B, et al. Among authors: troise f. Biomed Res Int. 2019 Dec 28;2019:6051870. doi: 10.1155/2019/6051870. eCollection 2019. Biomed Res Int. 2019. PMID: 31976323 Free PMC article.
Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer.
D'Alise AM, Nocchi L, Garzia I, Seclì L, Infante L, Troise F, Cotugno G, Allocca S, Romano G, Lahm A, Leoni G, Sasso E, Scarselli E, Nicosia A. D'Alise AM, et al. Among authors: troise f. Front Immunol. 2023 Apr 26;14:1156714. doi: 10.3389/fimmu.2023.1156714. eCollection 2023. Front Immunol. 2023. PMID: 37180141 Free PMC article.
26 results